S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Credit Suisse, UBS shares plunge after takeover announcement
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Niinistö: Sweden security OK if Finland joins NATO first
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Nations approve key UN science report on climate change
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Scottish independence at crossroads in testy SNP leader race
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Credit Suisse, UBS shares plunge after takeover announcement
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Niinistö: Sweden security OK if Finland joins NATO first
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Nations approve key UN science report on climate change
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Scottish independence at crossroads in testy SNP leader race
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Credit Suisse, UBS shares plunge after takeover announcement
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Niinistö: Sweden security OK if Finland joins NATO first
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Nations approve key UN science report on climate change
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Scottish independence at crossroads in testy SNP leader race
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.36
Credit Suisse, UBS shares plunge after takeover announcement
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Gunmen kill 9 Chinese at mine in Central African Republic
Niinistö: Sweden security OK if Finland joins NATO first
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Nations approve key UN science report on climate change
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Free Stock Analysis Report: Take Control of Your Stocks (Ad)pixel
Scottish independence at crossroads in testy SNP leader race
Swiss bank USB is acquiring smaller rival Credit Suisse for over $3 billion
NASDAQ:CHFS

Nuwellis - CHFS Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$4.52
$5.54
50-Day Range
$3.53
$6.02
52-Week Range
$4.86
$37.50
Volume
305,376 shs
Average Volume
467,323 shs
Market Capitalization
$29.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

CHFS stock logo

About Nuwellis (NASDAQ:CHFS) Stock

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Receive CHFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

CHFS Stock News Headlines

Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Form 424B4 Nuwellis, Inc. - StreetInsider.com
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Why Is Nuwellis (NUWE) Stock Up 110% Today?
See More Headlines
Receive CHFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

CHFS Company Calendar

Last Earnings
3/01/2021
Today
3/20/2023

Industry, Sector and Symbol

Industry
Electromedical Equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CHFS
Previous Symbol
NASDAQ:SSH
Fax
N/A
Employees
66
Year Founded
N/A

Profitability

Net Income
$-18,110,000.00
Net Margins
-254.26%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$5.51 million
Book Value
$12.79 per share

Miscellaneous

Free Float
N/A
Market Cap
$29.04 million
Optionable
Not Optionable
Beta
1.55

Key Executives

  • Nestor Jaramillo
    President, Chief Executive Officer, CFO & Director
  • Vitaliy Epshteyn
    Senior Vice President-Operations & Engineering
  • David Lerner
    Chief Technology Officer
  • Thomas P. Lynch
    Secretary, Chief Legal & Compliance Officer
  • Laurent Duhoux
    Vice President-International Business Development













CHFS Stock - Frequently Asked Questions

How were Nuwellis' earnings last quarter?

Nuwellis, Inc. (NASDAQ:CHFS) issued its quarterly earnings data on Monday, March, 1st. The company reported ($1.57) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.91) by $0.34. The business earned $2.04 million during the quarter. Nuwellis had a negative trailing twelve-month return on equity of 173.61% and a negative net margin of 254.26%.

When did Nuwellis' stock split?

Nuwellis's stock reverse split on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Nuwellis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nuwellis investors own include Biocept (BIOC), Immutep (IMMP), Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Zosano Pharma (ZSAN), Avinger (AVGR), Co-Diagnostics (CODX), iBio (IBIO), Inovio Pharmaceuticals (INO) and Onconova Therapeutics (ONTX).

What is Nuwellis' stock symbol?

Nuwellis trades on the NASDAQ under the ticker symbol "CHFS."

What is Nuwellis' stock price today?

One share of CHFS stock can currently be purchased for approximately $4.81.

How much money does Nuwellis make?

Nuwellis (NASDAQ:CHFS) has a market capitalization of $29.04 million and generates $5.51 million in revenue each year. The company earns $-18,110,000.00 in net income (profit) each year or ($279.28) on an earnings per share basis.

How can I contact Nuwellis?

Nuwellis' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The official website for the company is www.chf-solutions.com. The company can be reached via phone at (952) 345-4200 or via email at ir@chf-solutions.com.

This page (NASDAQ:CHFS) was last updated on 3/20/2023 by MarketBeat.com Staff